摘要
目的探讨胺碘酮对快速室上性心律失常的临床治疗效果。方法选择81例发作至就诊时间<48h,病程<6个月,有明显不适症状的急诊室上性心律失常患者,按入院先后顺序及治疗用药随机分为胺碘酮组(41例)与心律平组(40例)。观察急诊24h内两组患者转复有效率和不良反应。结果碘酮组转复率85.4%(35/41),心律平组70%(28/40)。两组转复率比较有显著差异(P<0.05);两组在血压、心律、神经系统等副作用方面比较无显著性差异(P>0.05),均未见严重不良反应病例出现。结论胺碘酮对快速室上性心律失常的疗效较佳,可作为治疗该病的首选药物。
Objective To explore the effect of low-dose amiodarone in treatment of fast supraventricular arrhythmia.Methods 81 patients with onset to treatment time of 48h,duration less than 6 months,there are obvious acute symptoms in patients with supraventricular arrhythmias.According to the order of admission,they were randomly divided into treatment group(41 patients,amiodarone group),the control group(40 patients,propafenone group).The treatment group received amiodarone and control group received propafenone therapy.Theemergency cardioversion efficient and adverse reaction were observed.Results The rate of amiodarone cardioversion group and propafenone group were 85.4%(35/41) and 70%(28/40).Cardioversion rate between the two groups were significantly different(P0.05).The blood pressure,heart rate,nervous system side effects of the two group were no significant difference(P0.05).Conclusion It is effective to treat supraventricular arrhythmia with amiodarone.
出处
《西部医学》
2011年第6期1026-1027,共2页
Medical Journal of West China
关键词
心律失常
胺碘酮
治疗应用
Arrhythmia
Amiodarone
Therapeutic use